Using electronic monitoring to improve patient compliance in hematology treatments
Official title: Evaluation of the Impact of Electronic Monitoring on Patient Compliance in Hematology
Run by Private Hospital of Confluent, France · NCT06713811 · Data updated 2026-11-12
This study is testing if using electronic monitoring can help people with blood disorders stick to their oral treatments better and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Private Hospital of Confluent, France Academic / other |
| Drugs / interventions | immunotherapy, CAR T, Chimeric Antigen Receptor |
| Locations | 3 sites (Amiens and 2 other locations) |
| Status | Recruiting |
| Started | May 22, 2025 |
| Main results expected | May 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT06713811 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with hemopathies who have been prescribed oral therapy for more than six months.
✕Probably not a fit
Patients expected to be on oral treatment for less than six months or those with certain active cancers or mental health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of electronic monitoring in enhancing patient compliance with oral therapies for hematological conditions. It focuses on patients undergoing treatment for hemopathies, particularly those on long-term oral medications. By utilizing telemonitoring, the study aims to detect and manage adverse effects in real-time, thereby improving treatment adherence and potentially impacting patient outcomes. The study includes patients who have been on oral therapy for over six months and excludes those with certain conditions that may affect compliance.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and outcomes for patients with hematological disorders.
How similar studies have gone: Other studies have shown promise in using telemonitoring to improve treatment adherence, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Follow-up for haemopathy justifying initiation of oral therapy (one or more authorized molecules) for more than 6 months (1st line of treatment or more), * Intravenous treatment may be associated with it, in accordance with international recommendations (immunotherapy, corticosteroid therapy, other), * Patient affiliated to a social security scheme, * Patient having given written consent prior to any specific study procedure. Exclusion Criteria: * Oral treatment expected to last \< 6 months, * Cerebral tumor involvement, * Other active cancer \< 3 years, excluding skin, prostate and cervical carcinomas treated by surgery alone, * Pregnancy or breast-feeding * Persons deprived of their liberty, under guardianship or curatorship, * Dementia, mental alteration or psychiatric pathology that could compromise the patient's informed consent and/or compliance with the protocol and trial follow-up, * Patient unable to undergo protocol monitoring for psychological, social, family or geographical reasons. * No Internet connection * No telephone line
Where it's running
-
Clinique de l'Europe
Amiens, France Recruiting -
Clinique de la Baie
Morlaix, France Recruiting -
Hôpital Privé du Confluent
Nantes, France Recruiting
Study contacts
- Study coordinator: Katell Le Dû, MD
- Email: dr.ledu@groupeconfluent.fr
- Phone: +33 6 15 24 60 67
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.